| 注册
首页|期刊导航|实用医学杂志|中成药辨证论治慢性肾脏病3-4期的多中心前瞻性临床研究

中成药辨证论治慢性肾脏病3-4期的多中心前瞻性临床研究

孟元 杨彦芳 刘洋 任建伟 程虹 刘建平 张胜容 刘宝利 李靖 赵轶雯 王雨 赵静 赵文景 葛楠

实用医学杂志Issue(16):2658-2662,5.
实用医学杂志Issue(16):2658-2662,5.DOI:10.3969/j.issn.1006-5725.2014.16.044

中成药辨证论治慢性肾脏病3-4期的多中心前瞻性临床研究

Prospective multicenter study on syndrome differentiation-based treatment with traditional Chinese medicine for Chronic Kidney Disease (CKD3-4)

孟元 1杨彦芳 2刘洋 3任建伟 4程虹 5刘建平 6张胜容 1刘宝利 1李靖 7赵轶雯 8王雨 1赵静 1赵文景 1葛楠1

作者信息

  • 1. 100010 北京市,首都医科大学附属北京中医医院
  • 2. 100029 北京市,中日友好医院
  • 3. 100853 北京市,解放军总医院
  • 4. 100012 北京市,航空总医院
  • 5. 100029 北京市,首都医科大学附属安贞医院
  • 6. 100029 北京市,北京中医药大学循证医学中心
  • 7. 100700 北京市,北京中医药大学东直门医院
  • 8. 100050 北京市,首都医科大学附属天坛医院
  • 折叠

摘要

Abstract

Objective To study the clinical curative effect of syndrome differentiation-based treatment with traditional Chinese medicine on patient with Chronic Kidney Disease (CKD3-4). Method According to prospective multicenter randomized controlled study which was applied to the patients with CKD3-4 , the total of 339 patients were divided into two groups. To one group as standard including 167 patients ,the other including 172 patients. Chinese Traditional Patent Medicine single or combined-prescription oral treatment according to syndrome differentiation-based treatment was employed. To the other group as reference , Chinese Traditional Patent Medicine oral treatment according to experienced rule was applied. The clinical curative effect results were obtained after a 24 weeks-treatment. Result The Scr ,eGFR and UTP with CKD3 in standard group illustrate statistics significance (P<0.05). On the opposite, those of the reference group remain insignificance (P > 0.05). The clinical curative effect result of patient in standard group was better than that of reference group. About the clinical curative effect of CKD4, no statistics significance difference (P > 0.05) could be found between groups or between patients in one group. The TCM score of patient with CKD3-4 in standard group have improved (P < 0.05) according to baseline. However, that of reference group did not show any statistics significance (P > 0.05). Conclusion Syndrome differentiation-based treatment with traditional Chinese medicine illustrated a better result in protection of renal function, reduction in urinary protein and decline in TCM score than the treatment according to experienced rule.

关键词

慢性肾脏病/3-4期/中成药/辨证论治

Key words

Chronic Kidney Disease (CKD3-4)/Chinese Traditional Patent Medicine/Syndrome differentiation-based treatment

引用本文复制引用

孟元,杨彦芳,刘洋,任建伟,程虹,刘建平,张胜容,刘宝利,李靖,赵轶雯,王雨,赵静,赵文景,葛楠..中成药辨证论治慢性肾脏病3-4期的多中心前瞻性临床研究[J].实用医学杂志,2014,(16):2658-2662,5.

基金项目

首都医学科技发展基金资助课题 ()

实用医学杂志

OA北大核心CSTPCD

1006-5725

访问量0
|
下载量0
段落导航相关论文